Endothelial-to-Mesenchymal Transition and Inflammation Play Key Roles in Cyclophilin A–Induced Pulmonary Arterial Hypertension
- 24 August 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 76 (4) , 1113-1123
Abstract
Oxidative stress and inflammation play key roles in development of pulmonary arterial hypertension (PAH). We previously reported that an endothelial cell (EC)-specific cyclophilin A overexpression mouse developed many characteristics of PAH. In other models of cardiovascular disease, cyclophilin A stimulates smooth muscle proliferation and vascular inflammation, but mechanisms responsible for PAH have not been defined. In particular, the contribution of endothelial-to-mesenchymal transition in cyclophilin A-mediated PAH has not been studied. We identified increased levels of cyclophilin A in endothelial and neointimal cells of pulmonary arteries in patients with PAH and animal pulmonary hypertension models. In the EC-specific cyclophilin A overexpression mouse that exhibited features characteristic of PAH, lineage tracing showed high level expression of mesenchymal markers in pulmonary ECs. A significant number of mesenchymal cells in media and perivascular regions of pulmonary arterioles and alveoli were derived from ECs. Pulmonary ECs isolated from these mice showed phenotypic changes characteristic of endothelial-to-mesenchymal transition in culture. Cultured pulmonary ECs stimulated with extracellular cyclophilin A and acetylated cyclophilin A demonstrated functional changes associated with endothelial-to-mesenchymal transition such as increased cytokine release, migration, proliferation, and mitochondrial dysfunction. Acetylated cyclophilin A stimulated greater increases for most features of endothelial-to-mesenchymal transition. In conclusion, extracellular cyclophilin A (especially acetylated form) contributes to PAH by mechanisms involving increased endothelial-to-mesenchymal transition, cytokine release, EC migration, proliferation, and mitochondrial dysfunction; strengthening the basis for studying cyclophilin A inhibition as a therapy for PAH.Keywords
This publication has 43 references indexed in Scilit:
- Mitochondrial morphology transitions and functions: implications for retrograde signaling?American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2013
- Inflammatory Cytokines Promote Mesenchymal Transformation in Embryonic and Adult Valve Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Molecular pathogenesis of pulmonary arterial hypertensionJournal of Clinical Investigation, 2012
- Cyclophilin A Promotes Cardiac Hypertrophy in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E–deficient miceJournal of Experimental Medicine, 2010
- Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiationRespiratory Research, 2009
- Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II–induced aortic aneurysmsNature Medicine, 2009
- Interleukin-6 Overexpression Induces Pulmonary HypertensionCirculation Research, 2009
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- Increased plasma monocyte chemoattractant protein‐1 level in idiopathic pulmonary arterial hypertensionRespirology, 2006